Gallbladder Clinical Trials

35 recruitingLast updated: May 13, 2026

There are 35 actively recruiting gallbladder clinical trials across 19 countries. Studies span Not Applicable, Phase 2, Phase 3, Early Phase 1, Phase 1. Top locations include Cleveland, Ohio, United States, Guangzhou, Guangdong, China, Aurora, Illinois, United States. Updated daily from ClinicalTrials.gov.


Gallbladder Trials at a Glance

35 actively recruiting trials for gallbladder are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Cleveland, Guangzhou, and Aurora. Lead sponsors running gallbladder studies include Banaras Hindu University, Hepatopancreatobiliary Surgery Institute of Gansu Province, and Cancer Research UK.

Browse gallbladder trials by phase

Treatments under study

About Gallbladder Clinical Trials

Looking for clinical trials for Gallbladder? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gallbladder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gallbladder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 35 trials

Recruiting
Phase 2

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

Recurrent Mucosal MelanomaMucosal MelanomaAnal Melanoma+14 more
National Cancer Institute (NCI)101 enrolled147 locationsNCT05111574
Recruiting

Integrated Cancer Repository for Cancer Research

Breast CancerLiver CancerEsophageal Cancer+47 more
University of Nebraska999,999 enrolled42 locationsNCT02012699
Recruiting

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+9 more
Seattle Children's Hospital200 enrolled1 locationNCT06315179
Recruiting
Early Phase 1

Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma

Gallbladder Adenocarcinoma
West Virginia University10 enrolled1 locationNCT05430035
Recruiting
Phase 2

Agnostic Therapy in Rare Solid Tumors

Cancer of Unknown PrimarySoft Tissue SarcomaCholangiocarcinoma+38 more
Instituto do Cancer do Estado de São Paulo28 enrolled8 locationsNCT06638931
Recruiting
Phase 1

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

Intrahepatic CholangiocarcinomaGallbladder CarcinomaMetastatic Malignant Neoplasm in the Peritoneum+5 more
City of Hope Medical Center12 enrolled1 locationNCT05285358
Recruiting
Phase 2

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Esophageal AdenocarcinomaGastric AdenocarcinomaPancreas Adenocarcinoma+6 more
Yale University54 enrolled1 locationNCT07282912
Recruiting

Impact of Pringle Maneuver on Postoperative Gallbladder Diseases After Hepatectomy

CholelithiasisGallbladder Diseases
West China Hospital2,000 enrolled8 locationsNCT07452848
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting
Phase 2

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Biliary Tract CancerCholangiocarcinomaGallbladder Cancer+2 more
Case Comprehensive Cancer Center27 enrolled2 locationsNCT07146646
Recruiting

EULAT Eradicate GBC

Gallbladder CancerGallstone Disease
Centre Paul Strauss15,000 enrolled36 locationsNCT06192719
Recruiting
Not Applicable

The Optimal Measurement Time for the New Gallbladder Function Assessment Method

Gallbladder; Functional Disturbance
Hepatopancreatobiliary Surgery Institute of Gansu Province120 enrolled5 locationsNCT07321431
Recruiting
Not Applicable

Target-specific immunoPET Imaging of Digestive System Carcinoma

MalignancyLiver CancerPancreatic Cancer+12 more
RenJi Hospital400 enrolled1 locationNCT06715839
Recruiting
Not Applicable

A Strategy for Gallstone Expulsion Through Dietary Therapy

Gallbladder Stone
Hepatopancreatobiliary Surgery Institute of Gansu Province100 enrolled1 locationNCT06699030
Recruiting
Not Applicable

Surgical Techniques: Robotic Versus Conventional Laparoscopic Cholecystectomy IN Benign Gallbladder Disease

GallstonesCholecystectomyCholecystectomy, Laparoscopic+2 more
Portsmouth Hospitals NHS Trust276 enrolled1 locationNCT07119203
Recruiting
Not Applicable

One vs. Two Stents for Gallbladder Disease

Biliary colicCholecystitisRecurrent Cholecystitis+1 more
Mayo Clinic30 enrolled1 locationNCT07222527
Recruiting
Phase 2Phase 3

DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations

Ovarian NeoplasmsColorectal NeoplasmsUrinary Bladder Neoplasm+8 more
Cancer Research UK30 enrolled27 locationsNCT05786716
Recruiting
Not Applicable

STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy

Gallbladder CancerCholecystitisCholelithiasis
Helsinki University Central Hospital850 enrolled1 locationNCT06123117
Recruiting

Bile Omics for Diagnosing Indeterminate Biliary Strictures

Pancreatic CancerCholangiocarcinomaGallbladder Cancer and Extrahepatic Cholangiocarcinoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine260 enrolled1 locationNCT07007832
Recruiting
Phase 3

Evaluating Novel Therapies in ctDNA Positive GI Cancers

Hepatocellular CarcinomaGastric AdenocarcinomaPancreatic Adenocarcinoma+4 more
Georgetown University20 enrolled3 locationsNCT05482516